Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

Neuroblastoma is the most common extracranial childhood solid tumor. The majority of high-risk neuroblastoma is resistant/refractory to the current high intensity therapy. Neuroblastoma lacks classical HLA Class I expression and exhibits low mutation burden, allowing neuroblastoma cells to evade CD8...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xao X., Shimada, Hiroyuki, Ikegaki, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232393/
https://www.ncbi.nlm.nih.gov/pubmed/35525858
http://dx.doi.org/10.1038/s41435-022-00172-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232393/
https://www.ncbi.nlm.nih.gov/pubmed/35525858
http://dx.doi.org/10.1038/s41435-022-00172-w

Ejemplares similares